Suchergebnisse - (Standardsuche:Subject:"angiotensin II "type1" receptor blockers")

PubPharm (12)

1

Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats

enthalten in: Journal of hypertension | 2022

von Ryuzaki, M. | Miyashita, K. | Sato, M. | +8

2

Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies

enthalten in: Journal of hypertension | 2012

von Verdecchia, P. | Dagenais, G. | Healey, J. | +14

CommentIn: J Hypertens. 2012 May;30(5):887-9. - PMID 22495133

3

Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice

enthalten in: Journal of hypertension | 2010

von Iwanami, J. | Mogi, M. | Tsukuda, K. | +5

4

Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats

enthalten in: Journal of hypertension | 2009

von Tamura, T. | Jamous, M. | Kitazato, K. | +4

5

Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia : in-vivo and in-vitro studies

enthalten in: Journal of hypertension | 2008

von Liu, H. | Kitazato, K. | Uno, M. | +6

6

Effects of angiotensin II type 1-receptor blockade on retinal endothelial function

enthalten in: Journal of hypertension | 2008

von Ott, C. | Schlaich, M. | Harazny, J. | +3

7

Myocardial fibrosis and diastolic dysfunction in patients with hypertension : results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

enthalten in: Journal of hypertension | 2007

von Müller-Brunotte, R. | Kahan, T. | López, B. | +4

CommentIn: J Hypertens. 2008 Jul;26(7):1497; author reply 1497-9. - PMID 18551029

8

Treatment of non-dipper hypertension with bedtime administration of valsartan

enthalten in: Journal of hypertension | 2005

von Hermida, R. | Calvo, C. | Ayala, D. | +4

CommentIn: J Hypertens. 2005 Oct;23(10):1799-801. - PMID 16148601

9

Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities : a 24-week randomized controlled trial

enthalten in: Journal of hypertension | 2005

von Scaglione, R. | Argano, C. | Corrao, S. | +3

10

How much echo left ventricular hypertrophy would be missed in diabetics by applying the Losartan Intervention For Endpoint Reduction electrocardiogram criteria to select patients for angiotensin receptor blockade?

enthalten in: Journal of hypertension | 2004

von Dawson, A. | Rana, B. | Pringle, S. | +3